|
| Status |
Public on Aug 20, 2016 |
| Title |
Transcriptional changes induced by Brd4 inhibitor, AZD5153, in cancer cell lines |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
We sequenced mRNA from 12 human cancer cell lines treated with DMSO or AZD5153 for 24h to determine compound mechanism of action
|
| |
|
| Overall design |
Measured mRNA levels in cell lines treated with either AZD5153 or DMSO for 24h
|
| |
|
| Contributor(s) |
Chen R, Dulak A |
| Citation(s) |
27573426 |
| |
| Submission date |
Aug 19, 2016 |
| Last update date |
May 15, 2019 |
| Contact name |
Huawei Chen |
| E-mail(s) |
Raymond.Chen@astrazeneca.com
|
| Organization name |
AstraZeneca
|
| Street address |
35 Gatehouse Dr
|
| City |
Waltham |
| State/province |
MA |
| ZIP/Postal code |
02451 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
| Samples (48)
|
|
| Relations |
| BioProject |
PRJNA339566 |
| SRA |
SRP082423 |
Less...
More...